Home The Word Brain My Amedeo FAQ Privacy About


Hanzi Hunter

Learning 500 Chinese characters in 30 days is possible.

Abstract • About

  Rheumatoid Arthritis

  Free Subscription


23.03.2026

2 Ann Rheum Dis
3 Arthritis Res Ther
1 Clin Exp Rheumatol
2 Clin Rheumatol
2 J Arthroplasty
1 J Rheumatol
1 PLoS One
1 Scand J Rheumatol


  Retrieve available abstracts of this week’s articles:
HTML format
 
 
Single Articles


    Ann Rheum Dis

  1. HUSS V, Bower H, Bjorklund M, Hellgren K, et al
    Risk of first and second primary keratinocyte cancers in relation to treatment of rheumatoid arthritis with JAKi, TNFi, and non-TNFi bDMARDs-a Swedish nationwide study.
    Ann Rheum Dis. 2026 Mar 12:S0003-4967(26)00090-7. doi: 10.1016/j.ard.2026.
    PubMed         Abstract available

  2. SMOLEN JS, Edwards CJ, Konzett V, Laskou F, et al
    EULAR recommendations for the management of rheumatoid arthritis with synthetic and biologic disease-modifying antirheumatic drugs: 2025 update.
    Ann Rheum Dis. 2026 Mar 12:S0003-4967(26)00075-0. doi: 10.1016/j.ard.2026.
    PubMed         Abstract available


    Arthritis Res Ther

  3. ZHAO H, Shu J, Yu F, Lu C, et al
    LncRNA MIAT inhibits osteoblast differentiation and function in rheumatoid arthritis via let-7i-5p/ CKIP-1 axis.
    Arthritis Res Ther. 2026 Mar 20. doi: 10.1186/s13075-026-03798.
    PubMed        

  4. ZHU D, Sun F, Zheng X, Cai W, et al
    Characteristics of CLA(+)Tregs in rheumatoid arthritis and their potential as biomarkers of treatment response.
    Arthritis Res Ther. 2026 Mar 19. doi: 10.1186/s13075-026-03791.
    PubMed        

  5. YE L, Wang X, Yin J, Shi H, et al
    FASN-mediated metabolic reprogramming drives CD4(+) T cell hyperactivation in Sjogren's syndrome via fatty acid oxidation-dependent oxidative phosphorylation.
    Arthritis Res Ther. 2026;28:71.
    PubMed         Abstract available


    Clin Exp Rheumatol

  6. HSIEH TY, Chen IC, Wu TS, Lo SM, et al
    Candidate pharmacogenetic signals at CCL2 and ITPA associated with JAK inhibitor response in Taiwanese rheumatoid arthritis.
    Clin Exp Rheumatol. 2026 Mar 12. doi: 10.55563.
    PubMed         Abstract available


    Clin Rheumatol

  7. SONG Z, Zhu D, Sun F, Geng J, et al
    CD161(+) Treg as a potential biomarker for evaluating disease activity and treatment efficacy in rheumatoid arthritis.
    Clin Rheumatol. 2026 Mar 20. doi: 10.1007/s10067-026-08056.
    PubMed         Abstract available

  8. YANG M, Xu F, Zhang B, Pi H, et al
    Age-stratified treatment response in rheumatoid arthritis: a systematic review, meta-analysis, and integrated genetic and single-cell evidence implicating IL6R/TYK2 signaling.
    Clin Rheumatol. 2026 Mar 18. doi: 10.1007/s10067-026-08029.
    PubMed         Abstract available


    J Arthroplasty

  9. HASHIMOTO K, Nakamura Y, Otsuka H, Takahashi N, et al
    The 10- to 23-Year Outcomes of Cemented Total Hip Arthroplasty Utilizing Impaction Bone Grafting for Severe Acetabular Bone Defects in Osteoarthritis and Rheumatoid Arthritis.
    J Arthroplasty. 2026 Mar 18:S0883-5403(26)00236.
    PubMed         Abstract available

  10. KUMAGAI K, Kubo M, Nosaka Y, Amano Y, et al
    Patient-Reported Outcomes and Satisfaction Following Total Knee Arthroplasty in Rheumatoid Arthritis: An Observational Cohort Study.
    J Arthroplasty. 2026 Mar 15:S0883-5403(26)00222.
    PubMed         Abstract available


    J Rheumatol

  11. ACHARYA S, Brewer C, Gomez AM, Younis S, et al
    NETosis-derived PADs mediate Citrullination of Oral Bacteria to promote Inflammation in Rheumatoid Arthritis.
    J Rheumatol. 2026 Mar 15:jrheum.2025-0792. doi: 10.3899/jrheum.2025-0792.
    PubMed         Abstract available


    PLoS One

  12. NISHISAKA K, Okano T, Imai T, Tsubosaka M, et al
    Mode of action-specific and cause-specific retention of biologic and targeted synthetic disease-modifying antirheumatic drugs in anti-SS-A antibody-positive rheumatoid arthritis: The ANSWER cohort study.
    PLoS One. 2026;21:e0344747.
    PubMed         Abstract available


    Scand J Rheumatol

  13. GUSKI LS, Pedder H, Andersn SE, Jurik AG, et al
    Effect of monotherapy with conventional synthetic disease-modifying anti-rheumatic drugs or glucocorticoids on radiographic progression in rheumatoid arthritis: a network meta-analysis of 64 treatment arms from 31 randomized controlled trials.
    Scand J Rheumatol. 2026 Mar 20:1-7. doi: 10.1080/03009742.2026.2631878.
    PubMed         Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Rheumatoid Arthritis is free of charge.

Privacy / Datenschutzerklärung | Imprint / Impressum